ArticleAlzheimer's & dementia (New York, N. Y.)2022

Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD mice.

Adrian L Oblak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.